Taro Pharmaceutical Industries (TARO)

Add to Watchlists Create an Alert
63.22 -0.60  -0.94%   NYSE May 23, 8:00PM BATS Real time Currency in USD

Taro Pharmaceutical Industries Shareholders Equity:

843.39M for Dec. 31, 2012
View Full Chart

Taro Pharmaceutical Industries Shareholders Equity Chart

    Taro Pharmaceutical Industries Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 843.39M
    Sept. 30, 2012 756.84M
    June 30, 2012 680.68M
    March 31, 2012 619.01M
    Dec. 31, 2011 567.26M
    Sept. 30, 2011 499.11M
    June 30, 2011 455.41M
    March 31, 2011 417.07M
    Dec. 31, 2010 381.31M
    Sept. 30, 2010 297.51M
    June 30, 2010 256.10M
    Dec. 31, 2009 292.97M
    Sept. 30, 2009 228.69M
    June 30, 2009 211.07M
    March 31, 2009 198.59M
    Dec. 31, 2008 164.22M
    Sept. 30, 2008 206.04M
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
       
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro
    June 30, 2000 Go Pro
    March 31, 2000 Go Pro
    Dec. 31, 1999 Go Pro
    Sept. 30, 1999 Go Pro
    June 30, 1999 Go Pro
    March 31, 1999 Go Pro
    Dec. 31, 1998 Go Pro
    March 31, 1998 Go Pro
    Dec. 31, 1997 Go Pro
    Sept. 30, 1997 Go Pro
    June 30, 1997 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    TARO Shareholders Equity Benchmarks

    Companies
    Perrigo Company 2.224B
    Valeant Pharmaceuticals International 3.587B
    Pernix Therapeutics 78.54M

    TARO Shareholders Equity Rankings

    Overall 81st percentile
    1459 of 8006
    Sector 86th percentile
    93 of 686 in Healthcare
    Industry 85th percentile
    10 of 68 in Drug Manufacturers - Specialty & Generic

    TARO Shareholders Equity Range, Past 5 Years

    Minimum 164.22M Dec 2008
    Maximum 843.39M Dec 2012
    Average 416.19M